WHO ICTRP trial
Case series study of Tiaogan Anshen Granule in treating chronic insomnia
ChiCTR2300070159 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300070159 |
|---|---|
| Public title | Case series study of Tiaogan Anshen Granule in treating chronic insomnia |
| Scientific title | Case series study of Tiaogan Anshen Granule in treating chronic insomnia |
| Primary sponsor | The First Affiliated Hospital of Guangdong Pharmaceutical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | chronic insomnia |
| Interventions | Tiaogan Anshen Granule Group:Tiaogan Anshen Granules |
| Registration date | Apr 4, 2023 |
| Target size | Tiaogan Anshen Granule Group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: